Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats
Authors:
- 9 January 2009
- journal article
- research article
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 458 (2) , 247-257
Abstract
The purpose of this study was to determine whether the long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats. Myocardial infarction (MI) was induced by left descending coronary artery ligation. Tempol was orally administered in drinking water (2 mmol/L), which was initiated 4 h after infarction and continued for 6 weeks. Tempol prevented not only the increases in left ventricular end-diastolic pressure and volume but also the decreases in ejection fraction and peak velocities of contraction in MI rats. The treatment normalized the increased renal sympathetic nerve activity (RSNA) and plasma norepinephrine level, as well as the enhanced cardiac sympathetic afferent reflex (CSAR; an excitatory cardiovascular reflex partially contributing to the sympathetic activation in chronic heart failure) and the RSNA responses to microinjection of angiotensin II into paraventricular nucleus in MI rats. Furthermore, tempol prevented the increased AT1 receptor protein expression and superoxide anion level in both paraventricular nucleus and rostral ventrolateral medulla in MI rats. In conclusion, long-term administration of tempol attenuates ventricular dysfunction and normalizes sympathetic neural control in MI rats. The normalization of the CSAR, levels of superoxide anions and AT1 receptor expression, and the response to angiotensin II in the paraventricular nucleus and rostral ventrolateral medulla may partially contribute to the beneficial effects of tempol on central sympathetic control.Keywords
This publication has 43 references indexed in Scilit:
- Role of Oxidant Stress on AT1 Receptor Expression in Neurons of Rabbits With Heart Failure and in Cultured NeuronsCirculation Research, 2008
- Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor- BCardiovascular Research, 2008
- The importance of exercise training in patients with chronic heart failureNursing Standard, 2006
- Simvastatin Therapy Normalizes Sympathetic Neural Control in Experimental Heart FailureCirculation, 2005
- Augmented Input From Cardiac Sympathetic Afferents Inhibits Baroreflex in Rats With Heart FailureHypertension, 2005
- Reactive oxygen species stimulate central and peripheral sympathetic nervous system activityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Increased Reactive Oxygen Species in Rostral Ventrolateral Medulla Contribute to Neural Mechanisms of Hypertension in Stroke-Prone Spontaneously Hypertensive RatsCirculation, 2004
- Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative StressHypertension, 2002
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984